SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 13.22% growth in the revenue at Rs. 16620.00 millions for the quarter ended March 2022 as compared to Rs. 14680.00 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 2210.00  millions from Rs. 2790.00 millions ,decline by -20.79%.OP of the company witnessed a marginal growth to 5440.00 millions from 5220.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 16620.00 14680.00 13.22 67420.00 64510.00 4.51 67420.00 64510.00 4.51
Other Income 610.00 910.00 -32.97 2040.00 1180.00 72.88 2040.00 1180.00 72.88
PBIDT 5440.00 5220.00 4.21 23040.00 23100.00 -0.26 23040.00 23100.00 -0.26
Interest 520.00 690.00 -24.64 2360.00 3340.00 -29.34 2360.00 3340.00 -29.34
PBDT 4920.00 4530.00 8.61 20680.00 19760.00 4.66 20680.00 19760.00 4.66
Depreciation 1470.00 1520.00 -3.29 6020.00 6100.00 -1.31 6020.00 6100.00 -1.31
PBT 3450.00 3010.00 14.62 14660.00 13660.00 7.32 14660.00 13660.00 7.32
TAX 1240.00 220.00 463.64 4750.00 2280.00 108.33 4750.00 2280.00 108.33
Deferred Tax 670.00 -390.00 -271.79 2220.00 -200.00 -1210.00 2220.00 -200.00 -1210.00
PAT 2210.00 2790.00 -20.79 9910.00 11380.00 -12.92 9910.00 11380.00 -12.92
Equity 846.20 846.20 0.00 846.20 846.20 0.00 846.20 846.20 0.00
PBIDTM(%) 32.73 35.56 -7.95 34.17 35.81 -4.56 34.17 35.81 -4.56

Torrent Pharma Share Price

4178.85 22.50 (0.54%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×